ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 178 filers reported holding ROCKET PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $40,467,750 | +714.7% | 1,975,000 | +690.0% | 5.40% | +698.7% |
Q2 2023 | $4,967,500 | -67.8% | 250,000 | -72.2% | 0.68% | -69.4% |
Q1 2023 | $15,417,000 | +5.0% | 900,000 | +20.0% | 2.21% | +28.4% |
Q4 2022 | $14,677,500 | +367.4% | 750,000 | +400.0% | 1.72% | +174.2% |
Q2 2020 | $3,140,000 | +1320.8% | 150,000 | +848.8% | 0.63% | +646.4% |
Q1 2020 | $221,000 | -95.7% | 15,809 | -92.9% | 0.08% | -93.3% |
Q4 2019 | $5,083,000 | – | 223,337 | – | 1.25% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
M28 Capital Management LP | 715,880 | $9,851,000 | 11.04% |
RTW INVESTMENTS, LP | 15,802,802 | $217,447,000 | 5.62% |
Amitell Capital Pte Ltd | 97,331 | $1,339,000 | 3.05% |
Prosight Management, LP | 276,802 | $3,809,000 | 3.00% |
TANG CAPITAL MANAGEMENT LLC | 1,265,900 | $17,419,000 | 2.64% |
Affinity Asset Advisors, LLC | 250,466 | $3,446,000 | 1.45% |
COWEN AND COMPANY, LLC | 1,000,000 | $13,760,000 | 1.33% |
Boxer Capital, LLC | 1,466,051 | $20,173,000 | 1.28% |
Cormorant Asset Management, LP | 868,550 | $11,951,000 | 0.90% |
MAVERICK CAPITAL LTD | 2,532,366 | $34,845,000 | 0.86% |